Ticker Details
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
IPO Date:	July 18, 2013
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 2.03%
Avg Daily Range (30 D):	$1.36 | 1.80%
Avg Daily Range (90 D):	$1.23 | 1.56%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.3M
Avg Daily Volume (90 D):	.32M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	2,513
Avg Institutional Trade:	$2.24M
Avg Institutional Trade (30 D):	$3.81M
Avg Institutional Trade (90 D):	$3.6M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.64M
Avg Closing Trade (30 D):	$4.27M
Avg Closing Trade (90 D):	$4.75M
Avg Closing Volume:	41.56K

News

Mar 27, 2026 @ 10:30 PM ANI Pharma Insider Sells 4,772 Shares as Revenue H... Source: Jonathan Ponciano

Feb 13, 2026 @ 11:50 AM ANI Pharmaceuticals to Discuss Fourth Quarter and ... Source: Na

Dec 28, 2025 @ 5:26 PM ANI Stock Is Up 49% This Past Year, Revenue Is Sur... Source: Jonathan Ponciano

Aug 29, 2025 @ 12:00 PM CG Oncology’s Executive Leadership to Parti... Source: Cg Oncology

Aug 8, 2025 @ 12:25 PM Cg Oncology (CGON) Q2 Loss Widens 93% Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.5	$1.24	$3.5
Diluted EPS	$3.32	$1.17	$3.32
Revenue	$883.37M	$247.06M	$883.37M
Gross Profit
Net Income / Loss	$78.34M	$27.49M	$78.34M
Operating Income / Loss	$111.09M	$34.77M	$111.09M
Cost of Revenue
Net Cash Flow	$140.73M	$22.98M	$140.73M
PE Ratio	23.60

Splits
Jul 18, 2013	1:6
Jun 04, 2012	1:6
Jun 03, 2002	1:10